OVERVIEW

Medical Summaries and Commentaries™: Update from San Francisco: Interpreting Therapeutic Advancements for Severe Asthma is organized by Physicians' Education Resource, LLC (PER) and will be held from Mar 29, 2019 - Mar 29, 2020.

Target Audience:
This activity is directed toward healthcare professionals specializing in immunology, allergy, pulmonology, primary care, and others interested in the care of patients with asthma.

Accreditation:
• CME: 1.25

Activity Overview:
This online activity is designed to update physicians on data presented at the American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting, held in February 2019 in San Francisco, CA. PER’s Medical Summaries and Commentaries™: Update from San Francisco: Interpreting Therapeutic Advancements for Severe Asthma online CME activity facilitates critical assessment and clinical integration of new evidence when appropriate. The activity reviews 8 abstracts with some of the most compelling and clinically relevant severe asthma presentations from the meeting. For each abstract, a short summary of key clinical data is accompanied by expert perspective that provides insight into how clinicians can apply these findings to their clinical practice to improve patient care.

Learning Objectives:
After successful completion of this activity, you should be better prepared to:
• Explain recent clinical trial findings on burden and phenotypes of asthma
• Integrate evidence-based diagnostic and therapeutic recommendations and therapeutic implications of new and emerging data into practice
• Incorporate best practices for effective management of patients with uncontrolled asthma based on new and emerging data

Benefits of Participation:
• Learn about emerging treatments for the management of severe asthma
• Hear about digital asthma programs that may improve management of severe asthma
• Learn about new research findings with approved biologic treatments for severe asthma
• Explore future directions for the prevention and management of exacerbations in severe asthma
• Be informed about recent clinical trials in severe asthma and their impact on clinical practice decisions

Additional details will be posted as soon as they are available.